A new study published in the journal of Cureus that interdialytic weight gain greater than 3 kg and left ventricular hypertrophy (LVH) were identified as key predictors of adverse outcomes among dialysis patients. While doctors have long known that these patients face higher heart risks, this research looks on how interdialytic weight gain (IDWG) plays a major role in triggering serious cardiovascular events. This research closely tracked cardiovascular outcomes like myocardial infarction, sudden cardiac death, atrial fibrillation, and cerebrovascular accidents. Overall mortality stood at 16%, with most deaths linked directly to cardiovascular causes, underscoring how vulnerable dialysis patients are to heart disease. Interdialytic weight gain and cardiovascular risk in haemodialysis patients with chronic kidney disease: Findings from a prospective cohort study.